No Data
No Data
No Data
Aosaikang Pharma's Unit Gets Nod to Market Isavuconazole Sulfate for Injection
Beijing Aosaikang Pharmaceutical's (SHE:002755) unit, Jiangsu Aosaikang Pharmaceutical, obtained a drug registration certificate from China's National Medical Products Administration for its isavucona
Express News | Osecon: The subsidiary obtained a drug registration certificate for injectable isaconazole sulfate
The biomedical sector fluctuated higher, and Weixinkang went up and down in a straight line. Osecon was previously closed, and Aoxiang Pharmaceutical, Heyuan Biotech, Haichuang Pharmaceutical, and Bohui Innovation had the highest gains.
The biomedical sector fluctuated higher, and Weixinkang went up and down in a straight line. Osecon was previously closed, and Aoxiang Pharmaceutical, Heyuan Biotech, Haichuang Pharmaceutical, and Bohui Innovation had the highest gains.
Osecon (002755.SZ): net loss of 149 million yuan in 2023
On April 28, Ge Longhui (002755.SZ) released its 2023 annual report. During the reporting period, the company's operating income was 1,443 million yuan, a year-on-year decrease of 22.92%; net loss attributable to shareholders of listed companies was 149 million yuan; net loss attributable to shareholders of listed companies after deducting non-recurring profit and loss was 227 million yuan; basic loss per share was 0.16 yuan/share.
Osecon (002755.SZ) announced first-quarter results, net profit of 31.5547 million yuan, turning a loss into a profit
According to Zhitong Finance App News, Osecon (002755.SZ) released its report for the first quarter of 2024. The company's operating income was 448 million yuan, up 32.47% year on year; net profit attributable to shareholders of listed companies was 31,5447 million yuan, which turned a loss into a profit; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 235.361 million yuan; basic income per share was 0.03 yuan/share.
Pharmaceutical stocks continued to rise in the afternoon. Osecon moved up the market. BeiGene Shenzhou and Hengrui Pharmaceuticals both rose more than 4%, and the weights of the pharmaceutical industry such as Kangde, Aier Ophthalmology, and Mindray Healt
Pharmaceutical stocks continued to rise in the afternoon. Osecon moved up the market. BeiGene Shenzhou and Hengrui Pharmaceuticals both rose more than 4%, and the weights of the pharmaceutical industry such as Kangde, Aier Ophthalmology, and Mindray Healthcare collectively strengthened.
No Data